MARKET

RDHL

RDHL

Redhill Biopharm
NASDAQ
0.7015
-0.0085
-1.20%
Closed 16:10 07/09 EDT
OPEN
0.7204
PREV CLOSE
0.7100
HIGH
0.7500
LOW
0.6850
VOLUME
55.61K
TURNOVER
0
52 WEEK HIGH
3.310
52 WEEK LOW
0.6850
MARKET CAP
4.27M
P/E (TTM)
-5.0107
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RDHL last week (0629-0703)?
Weekly Report · 4d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 07/01 12:05
RedHill Biopharma Reschedules 2026 AGM to Add Proposal, Seeks Approval to Scrap Par Value
TipRanks · 07/01 11:27
RedHill Biopharma Expands ATM ADS Offering Capacity in U.S. Market
TipRanks · 06/29 11:28
Weekly Report: what happened at RDHL last week (0622-0626)?
Weekly Report · 06/29 10:01
RedHill Biopharma Sets July 28, 2026 AGM to Vote on Board, Auditor and Chairman-CEO Role
TipRanks · 06/25 11:32
RedHill Biopharma Closes $6 Million Private Placement to Fund Potential Acquisition
TipRanks · 06/22 21:17
RedHill Biopharma Raises $6 Million in June 2026 Private Placement of ADSs and Warrants
TipRanks · 06/22 20:28
More
About RDHL
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.

Webull offers RedHill Biopharma Ltd (ADR) stock information, including NASDAQ: RDHL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDHL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RDHL stock methods without spending real money on the virtual paper trading platform.